Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromat…
Medical - Diagnostics & Research
US, Santa Clara [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q2 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -17.80 | 2.15 | 2.61 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 26.58 | 2.88 | 2.27 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q2 | Δ in % | |
|---|---|---|---|---|
| Book Value | 5.95 | 21.21 | 20.02 | |
| Cash | 4.74 | 5.70 | 5.45 | |
| Capex | -22.20 | -0.35 | -0.29 | |
| Free Cash Flow | -46.94 | 0.78 | 1.48 | |
| Revenue | -7.13 | 5.37 | 5.78 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q2 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 0.39 | 0.54 | 0.54 | |
| Operating Margin | -4.52 | 0.23 | 0.24 | |
| ROA | -35.71 | 0.03 | 0.04 | |
| ROE | -39.01 | 0.05 | 0.08 | |
| ROIC | -37.82 | 0.03 | 0.05 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of A is permitted for members.
5
Growth
The "Growth Entry" for the Focus of A is permitted for members.
6
Leverage & Liquidity